INT26859

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.29
First Reported 1989
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 10
Total Number 10
Disease Relevance 3.05
Pain Relevance 1.37

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

Anatomy Link Frequency
eye 1
blood 1
ileum 1
skin 1
Ventral 1
Vms1 (Mus musculus)
Pain Link Frequency Relevance Heat
Enkephalin 7 99.98 Very High Very High Very High
headache 13 97.46 Very High Very High Very High
transdermal 21 96.30 Very High Very High Very High
antidepressant 6 94.84 High High
Analgesic 3 93.00 High High
narcan 2 91.08 High High
depression 46 86.36 High High
Opioid 1 84.00 Quite High
MU agonist 1 80.20 Quite High
alcohol 4 71.96 Quite High
Disease Link Frequency Relevance Heat
Pressure And Volume Under Development 3 99.50 Very High Very High Very High
Sleep Disorders 24 97.76 Very High Very High Very High
Headache 13 97.46 Very High Very High Very High
Reprotox - General 3 17 96.12 Very High Very High Very High
Anxiety Disorder 18 95.32 Very High Very High Very High
Osteoporosis 13 88.68 High High
Depression 54 86.36 High High
Gallbladder Disease 4 84.48 Quite High
Uterine Hemorrhage 6 83.48 Quite High
Endometriosis (extended) 170 82.76 Quite High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Phenylephrine elevated blood pressure and elicited an initial VMS activity decline and a subsequent rise in VMS activity in all states, although the initial decline during quiet sleep occurred only in rostral placements.
Negative_regulation (decline) of VMS in blood associated with pressure and volume under development
1) Confidence 0.29 Published 2000 Journal Am. J. Physiol. Regul. Integr. Comp. Physiol. Section Abstract Doc Link 10749799 Disease Relevance 0.10 Pain Relevance 0
Ventral medullary surface (VMS) activity declines during rapid eye movement (REM) sleep, suggesting a potential for reduced VMS responsiveness to blood pressure challenges during that state.
Negative_regulation (declines) of VMS in Ventral
2) Confidence 0.29 Published 2000 Journal Am. J. Physiol. Regul. Integr. Comp. Physiol. Section Abstract Doc Link 10749799 Disease Relevance 0.07 Pain Relevance 0
Ventral medullary surface (VMS) activity declines during rapid eye movement (REM) sleep, suggesting a potential for reduced VMS responsiveness to blood pressure challenges during that state.
Negative_regulation (reduced) of VMS in eye
3) Confidence 0.29 Published 2000 Journal Am. J. Physiol. Regul. Integr. Comp. Physiol. Section Abstract Doc Link 10749799 Disease Relevance 0.08 Pain Relevance 0
The transdermal estradiol spray was well tolerated by women with headache and breast tenderness being the most commonly reported adverse events.20 While the topical estradiol emulsion is effective at decreasing VMS, more studies need to be done to assess skin-to-skin transfer in more detail.
Negative_regulation (decreasing) of VMS in skin associated with transdermal and headache
4) Confidence 0.14 Published 2010 Journal Int J Gen Med Section Body Doc Link PMC2880349 Disease Relevance 0.17 Pain Relevance 0.26
In the ileum deprived of the serosa and muscolaris, DAGO reduced the delta Vms and delta Isc, but not the Vms and Isc, suggesting localization of the receptors responsible for this latter effect in the myenteric plexus and/or the muscularis mucosae.
Negative_regulation (reduced) of Vms in ileum associated with enkephalin
5) Confidence 0.06 Published 1989 Journal J. Pharm. Pharmacol. Section Abstract Doc Link 2570860 Disease Relevance 0 Pain Relevance 0.72
Most of these treatments fail to provide significant relief of VMS, and many women ultimately consult their physicians after these remedies fail.
Negative_regulation (relief) of VMS
6) Confidence 0.05 Published 2005 Journal Health Qual Life Outcomes Section Body Doc Link PMC1190205 Disease Relevance 0.90 Pain Relevance 0.29
5 years is no doubt beneficial for decreasing VMS, somatic symptoms, and resultant sleep and mood disturbances in women who experience bothersome menopausal symptoms.
Negative_regulation (decreasing) of VMS associated with reprotox - general 3
7) Confidence 0.05 Published 2005 Journal Health Qual Life Outcomes Section Body Doc Link PMC1190205 Disease Relevance 0.90 Pain Relevance 0
Epidemiology of VMS
Negative_regulation (Epidemiology) of VMS
8) Confidence 0.05 Published 2005 Journal Health Qual Life Outcomes Section Body Doc Link PMC1190205 Disease Relevance 0.60 Pain Relevance 0
However, we found impaired VMS and ADS in Yucheng women.
Negative_regulation (impaired) of VMS
9) Confidence 0.03 Published 2008 Journal Environ Health Perspect Section Body Doc Link PMC2235226 Disease Relevance 0 Pain Relevance 0
We found significant linear trends in the reduction in VMR, ADS, and VMS when reference, low-, intermediate-, and high-exposure groups were compared (Table 4).


Negative_regulation (reduction) of VMS
10) Confidence 0.02 Published 2008 Journal Environ Health Perspect Section Body Doc Link PMC2235226 Disease Relevance 0.23 Pain Relevance 0.11

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox